176 related articles for article (PubMed ID: 33661296)
1. Bone marrow infiltration by plasmablastic neoplasm: plasmablastic myeloma or plasmablastic lymphoma?
Eladl E; Chang H
Blood; 2021 Mar; 137(9):1268. PubMed ID: 33661296
[No Abstract] [Full Text] [Related]
2. [Plasmablastic lymphoma presenting clinical symptoms similar to plasmablastic myeloma].
Nakaya A; Nagate Y; Toda J; Yamashita Y; Hirose Y; Mori K; Shibayama H
Rinsho Ketsueki; 2023; 64(4):260-264. PubMed ID: 37121769
[TBL] [Abstract][Full Text] [Related]
3. Extramedullary sarcomatoid variant of plasmablastic plasmacytoma.
Majhi U; Sundersingh S; Murhekar K; Radha K
J Cancer Res Ther; 2017; 13(6):1078-1079. PubMed ID: 29237987
[No Abstract] [Full Text] [Related]
4. Plasmablastic lymphoma versus plasmablastic myeloma: an ongoing diagnostic dilemma.
Ahn JS; Okal R; Vos JA; Smolkin M; Kanate AS; Rosado FG
J Clin Pathol; 2017 Sep; 70(9):775-780. PubMed ID: 28249941
[TBL] [Abstract][Full Text] [Related]
5. Plasmablastic multiple myeloma with Dutcher bodies.
Jain D; Singh T
Indian J Pathol Microbiol; 2008; 51(3):442-3. PubMed ID: 18723987
[No Abstract] [Full Text] [Related]
6. From the archives of MD Anderson Cancer Center: Plasmablastic lymphoma presenting as a kidney mass in an immunocompetent patient: Case report and literature review.
Gietzen R; Muthukumarana V; Bhargava P; Vozniuk D; Thakral B; Medeiros LJ; Lyapichev KA
Ann Diagn Pathol; 2023 Dec; 67():152186. PubMed ID: 37541853
[TBL] [Abstract][Full Text] [Related]
7. Plasmablastic lymphoma of bone marrow: Report of a rare case and immunohistochemistry based approach to the diagnosis.
Sharma P; Sreedharanunni S; Koshy A; Prakash G; Sachdeva MUS; Malhotra P
Indian J Pathol Microbiol; 2019; 62(1):107-110. PubMed ID: 30706870
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity in the diagnosis of plasmablastic lymphoma, plasmablastic myeloma, and plasmablastic neoplasm: a scoping review.
Mori H; Fukatsu M; Ohkawara H; Oka Y; Kataoka Y; Taito S; Ikezoe T
Int J Hematol; 2021 Dec; 114(6):639-652. PubMed ID: 34462886
[TBL] [Abstract][Full Text] [Related]
9. Plasmablastic IgM multiple myeloma with hypocellular bone marrow.
Arter ZL; Miles D; Mignano S; Cordaro D; Roswarski J
Ann Hematol; 2020 Apr; 99(4):895-896. PubMed ID: 32055929
[No Abstract] [Full Text] [Related]
10. Morphologic heterogeneity and plasmablastic transformation in advanced plasmacytic/plasmablastic myeloma: a study of 35 serial bone marrow biopsies in 9 patients.
Paule B; Quillard J; Bennet P; Mariette X; Bisson M
Nouv Rev Fr Hematol (1978); 1989; 31(3):203-8. PubMed ID: 2616267
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features of plasmablastic multiple myeloma: a population-based cohort.
Møller HE; Preiss BS; Pedersen P; Kristensen IB; Hansen CT; Frederiksen M; Abildgaard N; Møller MB
APMIS; 2015 Aug; 123(8):652-8. PubMed ID: 26152595
[TBL] [Abstract][Full Text] [Related]
12. A challenging diagnosis of plasmablastic lymphoma: importance of integrating morpholgy immunohistochemistry and flow cytometry findings (case report).
Kmira Z; Ahmed G; Wided C; Wided M; Zeineb N; Nihed A; Yosra BY; Regaieg H; Nejia B; Abderrahim K
Pan Afr Med J; 2023; 45():158. PubMed ID: 37869229
[TBL] [Abstract][Full Text] [Related]
13. Plasmablastic myeloma in Taiwan frequently presents with extramedullary and extranodal mass mimicking plasmablastic lymphoma.
Chen BJ; Yuan CT; Yang CF; Ho CH; Lin YK; Su YZ; Chou HC; Chuang SS
Virchows Arch; 2022 Aug; 481(2):283-293. PubMed ID: 35657404
[TBL] [Abstract][Full Text] [Related]
14. CD3-positive plasmablastic B-cell neoplasms: a diagnostic pitfall.
Pan Z; Chen M; Zhang Q; Wang E; Yin L; Xu Y; Huang Q; Yuan Y; Zhang X; Zheng G; Yuan J
Mod Pathol; 2018 May; 31(5):718-731. PubMed ID: 29327711
[TBL] [Abstract][Full Text] [Related]
15. Plasmablastic transformation of multiple myeloma.
Lee CK; Ma ES; Shek TW; Lam CC; Au WY; Wan TS; Chan LC
Hum Pathol; 2003 Jul; 34(7):710-4. PubMed ID: 12874768
[TBL] [Abstract][Full Text] [Related]
16. Plasmablastic lymphoma with aberrant expression of CD3 and CD4.
Yan J; Sakhdari A
Int J Lab Hematol; 2022 Aug; 44(4):692-693. PubMed ID: 35060329
[No Abstract] [Full Text] [Related]
17. Transformation of a previously diagnosed diffuse large B-cell lymphoma to plasmablastic lymphoma.
Marini C; Baldaia H; Trigo F; Castillo JJ
Am J Hematol; 2016 Aug; 91(8):E324. PubMed ID: 27012155
[No Abstract] [Full Text] [Related]
18. Plasmablastic transformation of a double hit follicular lymphoma: An emerging entity.
Khodaiji S; Mahajan V; Satyakam KS; Amare PSK
Indian J Pathol Microbiol; 2024 Apr; 67(2):411-414. PubMed ID: 38391382
[TBL] [Abstract][Full Text] [Related]
19. An unusual case of myeloma.
Tate C; McKinley M; Seymour L
Pathology; 2018 Aug; 50(5):581-584. PubMed ID: 29921449
[No Abstract] [Full Text] [Related]
20. Treatment strategy in a patient showing borderline features between plasmablastic lymphoma and plasmablastic myeloma harboring a 17p deletion.
Yoshihara K; Yoshihara S; Matsuda I; Imado T; Matsuo S; Okada M; Shimizu Y; Hirota S; Fujimori Y
Ann Hematol; 2020 Jun; 99(6):1405-1407. PubMed ID: 32125468
[No Abstract] [Full Text] [Related]
[Next] [New Search]
